Stramsen Biotech, Inc.

HOUSTON, TX · Founded 2020 · CIK 0001943948 · Biotech · Private

Plant-based pharmaceutical compounds extracted and processed from botanical sources for therapeutic use

stramsenbiotech.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.0M
1 Form D · May 2024
29 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3300Starton Therapeutics Inc.—$11M
3301Knopp Biosciences LLC—$159M
3302Hemp Synergistics LLC—$1.5M
3303Stramsen Biotech, Inc.—$5.0M
3304Syncromune, Inc.—$56M
3305TuHURA Biosciences, Inc.—$21M
3306Century Therapeutics—$160M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Olaf BernardExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.